AQR Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $353K | Buy |
82,875
+37,214
| +82% | +$159K | ﹤0.01% | 2778 |
|
2025
Q1 | $172K | Buy |
+45,661
| New | +$172K | ﹤0.01% | 2921 |
|
2024
Q3 | – | Sell |
-12,125
| Closed | -$131K | – | 2844 |
|
2024
Q2 | $131K | Buy |
12,125
+704
| +6% | +$7.62K | ﹤0.01% | 2470 |
|
2024
Q1 | $129K | Buy |
11,421
+640
| +6% | +$7.25K | ﹤0.01% | 2313 |
|
2023
Q4 | $151K | Buy |
10,781
+728
| +7% | +$10.2K | ﹤0.01% | 2247 |
|
2023
Q3 | $124K | Buy |
+10,053
| New | +$124K | ﹤0.01% | 2204 |
|
2022
Q3 | – | Sell |
-70,973
| Closed | -$289K | – | 2280 |
|
2022
Q2 | $289K | Buy |
70,973
+29,457
| +71% | +$120K | ﹤0.01% | 1874 |
|
2022
Q1 | $177K | Buy |
+41,516
| New | +$177K | ﹤0.01% | 2086 |
|